Udayavni Special

CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DG


PTI, Jun 15, 2021, 5:46 PM IST

Bengaluru: The CSIR-Indian Institute of Chemical Technology (IICT) here and Bengaluru-based Anthem Biosciences Pvt Ltd have entered into an agreement for technology transfer and manufacture of anti- COVID drug 2-DG.

Studies have shown that 2-DG demonstrated quick recovery and reduction in oxygen dependence among moderate and severely affected COVID patients.

This drug, in the form of powder formulation, was earlier launched by Dr Reddy’s Laboratories in India, IICT said in a release.

Under the terms of the licence agreement, Anthem Biosciences Pvt Ltd, an integrated biopharmaceutical company, gets non-exclusive licence for the process know-how for synthesis of 2-DG (2-Deoxy-D-Glucose), it said.

”The agreement is in line with CSIR’s efforts to help people access various therapeutic options to combat COVID-19.

CSIR labs have undertaken clinical trials of various repurposed drugs for the treatment of COVID-19,” said Chandrasekhar, Director CSIR-IICT.

Anthem Biosciences Pvt Ltd is in the process of filing an application for getting the approval from DCGI in New Delhi and will subsequently manufacture and commercialise 2- DG from their facilities located at Bommasandra, Bangalore and Harohalli, Kanakapura, Karnataka, the release said.

Anthem Biosciences is in the forefront of working on niche and complex biopharmaceuticals, Ajay Bhardwaj, CEO and Founder the company said in the release.

”We have hands-on experience in the development and manufacturing of prodrug of 2-DG API for a discovery research biopharmaceutical company from the USA.

Because of our prior experience on 2-DG Prodrug, Post DCGI approval, we are geared up to supply multi-ton API to meet the immediate demand that might arise due to ongoing COVID-19 pandemic,” he said.

”We have also developed domestic vendors for key raw materials for uninterrupted supplies to manufacture 2-DG API.

Alternatively, we have developed an in-house process for key raw materials as we foresee the short supplies of these materials in coming months,” he added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Mekedatu: DKShi urges Bommai to start work on project immediately

Mumbai cops save Kerala man who hinted about suicide on Twitter

China, India miss UN deadline to update emissions targets

CM directs dists bordering Kerala to take up spl surveillance measures

Ajendra Shetty murder case: Police arrested prime accused

Likely to get message from BJP high command in 2 days on cabinet expansion: Bommai

1,987 new COVID-19 cases, 37 deaths in Karnataka


Related Articles More

1,987 new COVID-19 cases, 37 deaths in Karnataka

K’taka-Ker SRTC, private buses to stay off roads for a week from Aug 1

Districts with over 10% Covid positivity need to consider strict curbs, says Centre

Surge in Covid-19 cases in Kerala: CM to hold high-level meet

Surge in Covid-19 cases in Kerala: DC, Compol visit check post at Talapady

MUST WATCH

DC G Jagdish talked covid case in udupi

Accused should be punished

COMEDY KHILADIGALU’S RAKESH POOJARY ON HIS BBM DEGREE

WHY AGRICULTURE IS A BETTER PROFESSION THAN ANY OTHER JOBS?

Cattle thief at koppa

Latest Additions

Mangaluru: DRDWS’s water testing laboratory receives NABL accreditation

Mekedatu: DKShi urges Bommai to start work on project immediately

Shiradi ghat tunnel work to start soon?

Mumbai cops save Kerala man who hinted about suicide on Twitter

China, India miss UN deadline to update emissions targets

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.